Seven studies 11, 16, 24, 26-29 with 856 NSCLC patients were eligible to evaluate the correlation between overexpression of GOLPH3 and OS of cancer patients, including seven studies 11, 16, 24, 26-29 for univariate analysis and four studies 11, 16, 26, 28 for multivariate analysis (Table 4). The gene discussed is GOLPH3; the disease is cancer.